Astronics Corporation (ATRO – Q3FY20) – Commercial Aerospace, remains weak. General aviation is down but shows some signs of resilience whereas Defense and Government markets have remained strong through the pandemic.

Astronics Corporation and Xenex® Disinfection Services Inc. (“Xenex”), the world leader in UV disinfection for healthcare facilities, announced Xenex has awarded a $20 million contract to Astronics to assist in the manufacturing of Xenex’s unique LightStrike Germ-Zapping Robots.

Executive Summary

Financial Statements

– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Results Overview
– Company Overview
– Segment Performance
– Bookings & Backlog
– Acquisitions, Divestitures & Restructuring
– FY20 Outlook
– Conclusion

Historical Performance

– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– P/E Band
– Per Share Data

Product Performance and Key Developments

– Ownership
– Competitors
– Key Developments

Valuation and Consensus Performance

– Consensus view and analyst trend on stock
– Analyst Recommendations

Market Price Performance

CrispIdea Coverage Chart

No of Pages : 38